754 Pill - blue & white capsule/oblong, 18mm

Pill with imprint 754 is Blue & White, Capsule/Oblong and has been identified as Temozolomide 140 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 140 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 754

Temozolomide

Imprint: 754
Strength: 140 mg
Color: Blue & White
Size: 18.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Alkylating agents
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Zydus Pharmaceuticals (USA) Inc.
Manufacturer: Cadila Healthcare Limited
National Drug Code (NDC): 68382-0754
Inactive Ingredients: alcohol, ammonia, lactose anhydrous, butyl alcohol, FD&C Blue No. 1, FD&C Red No. 3, ferrosoferric oxide, gelatin, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, silicon dioxide, sodium lauryl sulfate, sodium starch glycolate type B potato, stearic acid, tartaric acid, titanium dioxide, water
Note: Inactive ingredients may vary.